Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention

Active

Assistance listing
93.326
Agency
Grant awards
43 $510,259,067 in federal obligations

Program facts

Also known as
Global Health Research
Assistance types
  • Cooperative Agreement
  • Formula Grant
  • Project Grant
Treasury account
  • 75-0943-5-5-551

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The Centers for Disease Control and Prevention (CDC) is funding vaccine-preventable disease prevention and response programs, immunization infrastructure, disease surveillance, and epidemiologic research on infectious diseases and global health threats, with the most recent awards distributed on July 1, 2025, under Assistance Listing 93.326.

The program has disbursed $510.3 million in combined federal dollars across 43 awards since 2015, with significant acceleration in 2025 when 20 awards were issued compared to four in 2024 and five in 2021. Recent activity is concentrated heavily in vaccine-preventable disease prevention: the July 2025 cohort includes large awards to California ($61.6 million), Michigan ($27.9 million), Louisiana ($24.8 million), and Alabama ($21 million) for vaccine distribution, immunization information systems modernization, provider engagement, and community outreach targeting vaccine hesitancy and disparities in underserved populations including rural, tribal, uninsured, and homeless communities. Earlier awards from 2019 to 2021 funded epidemiologic research on infectious disease threats in Kenya, Thailand, China, South Africa, Indonesia, Central America, and other countries; these represent capacity-building and disease surveillance efforts distinct from the recent vaccine-focused stream.

The program is predominantly Cooperative Agreements (93 percent of awards), with smaller shares of Formula Grants (5 percent) and Project Grants (2 percent). All four funders identified in the portfolio are CDC entities, making concentration measurement moot; CDC's various components administered all 43 awards. Award magnitudes range from sub-$1 million to over $61 million, with typical state immunization grants falling in the $3 million to $28 million range over five-year project periods.

Recent grant opportunities posted by CDC include RFA-JG-26-034 (Enhancing Understanding of and Preparedness for Public Health Threats in Kenya, due June 22, 2026, open to higher education institutions, nonprofits, and for-profits) and RFA-CK-26-104 (Eliminating Parasitic and Neglected Tropical Disease Threats, due July 6, 2026, eligible to state and tribal governments, nonprofits, and academic institutions). Earlier opportunities focused on malaria operations research, neglected tropical diseases, and infectious disease research in specific countries; these are no longer open to new applications.

Objective and description

Objective

CDC's global health efforts are to assist Ministries of Health and other international partners to plan, effectively manage and conduct public health research in the intent of public health protection; achieve US Government program and international

Description

This listing serves communities worldwide by supporting public health research, disease surveillance, and prevention programs that address major health challenges such as infectious diseases, chronic conditions, injuries, environmental health risks, and emerging global health security threats. What makes this effort unique is its focus on building local capacity, strengthening skills, systems, and partnerships so countries can sustainably protect the health of the populations now and in the future.

Eligibility

Applicant eligibility

Dependent on the Notice of Funding Opportunity (NOFO), eligibility may range from open, competitive, limited or single eligibility in accordance with authorizing legislation. May include non-profit organizations who may be domestic, international or Ministries of Health. Domestic academic institutions, community organizations, universities

Beneficiary eligibility

This will benefit individuals worldwide, including in the U.S., through collaborations with the national Ministries of Health and other organizations/institutions. This is only for research activities supported by CDC/ATSDR. For the definition of research, please see http:/www.cdc.gov/od/science/quality/resources

Uses of assistance

Applications will be externally peer reviewed and evaluated based on the evidence submitted which specifically describes the applicant's abilities to meet the following criteria: (1) the plans to develop and implement the study describing how study participants will be identified, enrolled, tested and followed; (2) the ability to enroll and follow an adequate number of eligible study participants to assure proper conduct of the study. This includes both demonstration of the availability potential study participants and the experience of the investigator in enrolling and following such persons; (3) the applicant's current activities in research, intervention and how they will be applied to achieving the objectives of the study; letters of support from cooperating organizations that demonstrate that nature and extent of such cooperation should be included; (4) the applicant's understanding of the research study objectives and, their ability, willingness and/or need to collaborate with CDC and researchers from other study sites in study design and analysis, including use of common forms, and sharing of specimens and data; (5) the plan to protect the rights and confidentiality of all participants and ensure adequate participation; (6) the size, qualifications and time allocation of the proposed staff and the availability of facilities to be used during the research study; (7) how the project will be administered to assure the proper management of the daily activities of the program; (8) the proposed schedule for accomplishing the activities of the research; including time frames; and (9) the quality of an evaluation plan which specifies methods and instruments to be used to evaluate the progress made in attaining research objectives. Recipients may only expand funds for reasonable program purposes, including personnel, travel, supplies and services, such as contractual Recipients may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment Reimbursement of pre-award costs is not allowed

Length and time phasing of assistance

Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient.

How to apply

Criteria for selecting proposals

Applications will be evaluated on the review criteria described in the Notice of Funding Opportunity Announcements (NOFOs). In general, the review and selection process of complete and responsive applications to the NOFO consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of CDC.

Award procedure

After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any.

Deadlines

Check Grants.gov for any relevant NOFO information regarding processes for applying for assistance.

Renewals

Project period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.

Grant opportunities

Opportunity Status Posted Applications due
Enhancing Understanding of and Preparedness for Public Health Threats Through Research in Kenya RFA-JG-26-034 Closed
Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad RFA-CK-26-104 Closed
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) PA-27-100 Open
Monitoring, Operations Research, Evaluation of Tools for Malaria Control and Prevention in Kenya RFA-CK-25-035 Closed
Collaborative research on influenza and other respiratory pathogens in South Africa RFA-IP-24-017 Closed
Advancing Public Health Research in Bangladesh RFA-GH-24-033 Closed
From Research to Action: Advancing evidence-based sustainable and equitable public health in Central America RFA-GH-23-002 Past —
Conducting Public Health Research with Universities in Thailand RFA-GH-23-003 Closed
Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and Elimination of Neglected Tropical Diseases RFA-GH-23-001 Closed
PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PA-22-177 Closed
PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-22-176 Closed
Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and Elimination of Malaria and Other Parasitic Diseases RFA-GH-22-001 Closed
PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-21-259 Closed
PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PA-21-260 Closed
Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory Pathogens in South Africa RFA-IP-21-003 Closed
Conducting Public Health Research in Thailand: Technical collaboration with the Ministry of Public Health (MOPH) in the Kingdom of Thailand RFA-GH-21-001 Closed
Advancing Public Health Research in Kenya RFA-GH-21-003 Closed
Strengthening Public Health Research and Implementation Science (Operations Research) to Control and Eliminate Infectious Diseases Globally RFA-GH-21-006 Closed
PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) PA-20-261 Closed
PHS 2020-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-20-260 Closed
PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PA-20-262 Closed
Conducting Public Health Research in Colombia RFA-GH-20-003 Closed
Conducting Public Health Research in Georgia RFA-GH-20-004 Closed
Conducting Public Health Research in South America RFA-GH-20-005 Closed
Malaria Operations Research to Improve Malaria Control and Reduce Morbidity and Mortality in Western Kenya RFA-GH-20-002 Closed
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required PA-19-273 Closed
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed PA-19-272 Closed
Advancing Infectious Disease Detection and Response in Liberia RFA-GH-19-013 Closed
Advancing Zoonotic Disease Detection through a One Health Approach in Ethiopia RFA-GH-19-001 Closed
Advancing Infectious Disease Detection and Response in Nigeria RFA-GH-19-010 Closed
Advancing Infectious Disease Detection and Response in Senegal RFA-GH-19-003 Closed
Advancing Public Health Research in Bangladesh RFA-GH-19-005 Closed
Advancing Infectious Disease Detection and Response in Indonesia RFA-GH-19-006 Closed
Advancing Infectious Disease Detection and Response in Uganda RFA-GH-19-008 Closed
Advancing Infectious Disease Detection and Response in Viet Nam RFA-GH-19-009 Closed
Advancing Infectious Disease Detection and Response in Ethiopia RFA-GH-19-007 Closed
Advancing Zoonotic Disease Detection through a One Health Approach in Thailand RFA-GH-19-002 Closed
Malaria Operations Research to Improve Malaria Control and Reduce Morbidity and Mortality in Malawi RFA-GH-19-015 Closed
Strengthening detection of emerging infectious diseases in India RFA-GH-18-002 Closed
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-18-574 Closed
Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and Elimination of Malaria and Neglected Tropical Diseases RFA-GH-18-005 Closed
Advancing Public Health Research in Central America (Belize, Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Nicaragua, Panama): Amendment 1 RFA-GH-18-004 Closed
PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) PA-17-302 Closed
Conducting Public Health Research in China RFA-GH-17-005 Closed
Institutional Research Collaboration between the Liverpool School of Tropical Medicine and the Centers for Disease Control and Prevention RFA-GH-15-0060102SUPP16 Closed
Institutional Research Collaboration between the Liverpool School of Tropical Medicine and the Centers for Disease Control and Prevention GH15-006-SUPP-16 Closed
Conducting Public Health Research in Thailand: technical collaboration with the Ministry of Public Health in the Kingdom of Thailand (MOPH) RFA-GH-16-003 Closed
Show 37 more

Latest 47 listed here. See the rest on GovTribe.

Grant awards

Award Recipient Federal obligations Awarded
Mississippi immunization and vaccine grant - mississippi's immunization program will continue to strengthen… NH23IP922726 Mississippi State Department Of Health $21,373,976
Strengthening vaccine-preventable disease prevention and response - the mission of the division of immunization at… NH23IP922724 Michigan Department Of Health And Human Services $27,962,700
EMI immiunization program - the republic of the marshall islands ministry of health and human services (mohhs)… NH23IP922722 Ministry Of Health In The Repu Blic Of The Marshall Islands $3,484,776
CDC-RFA-IP-25-0007 strengthening vaccine preventable disease prevention and response - strengthening… NH23IP922721 Maine Department Of Health And Human Services $4,093,081
Strengthening vaccine-preventable disease prevention and response in louisiana - 25-0007 - louisiana department of… NH23IP922720 Louisiana Department Of Health $24,849,467
25-0007 strengthening vaccine preventable disease prevention and response - the west virginia immunization services… NH23IP922713 West Virginia State Health Department $7,924,592
Immunization of children and adults, prevention of vaccine-preventable diseases, IIS data collection and analysis… NH23IP922712 VA State Board Of Health $15,835,748
Strengthening vaccine-preventable disease prevention and response NH23IP922711 Virgin Islands Department Of Health $3,260,727
CDC-RFA-IP25-0007 strengthening vaccine-preventable disease prevention and response - the pennsylvania immunization… NH23IP922708 Pennsylvania Department Of Health $18,873,342
This funding opportunity supports public health systems to protect people and communities from vaccine-preventable… NH23IP922706 Oklahoma State Department Of Health $21,071,920

Latest 10 of 43 listed here. See the rest on GovTribe.

Top recipients by federal obligations

10 of 43 recipients listed here. See the rest on GovTribe.

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2026 $16,179,840
FY2025 $54,107,744
FY2024 $174,001,150
FY2023 $18,459,061
FY2022 $46,638,822
FY2021 $33,070,319
FY2020 $40,615,540
FY2019 $15,356,872
FY2018 $12,305,285
FY2017 $13,387,290
FY2016 $16,942,258
FY2015 $715,588
Show all 12

Quick answers

What is Assistance Listing 93.326?

Assistance Listing 93.326 is Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention, a federal grant program run by Centers for Disease Control and Prevention (Department of Health and Human Services).

What is the CFDA number for Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention?

Its CFDA number is 93.326: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 93.326 awarded?

43 grant awards under 93.326 have obligated $510,259,067 in federal funds to 43 recipients.

Who receives the most funding from 93.326?

The recipients obligated the most under Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention are California Department Of Public Health ($61,577,204), Department Of Health Wyoming ($52,716,008) and Utah Department Of Health And Human Services ($42,019,284).

How much did 93.326 obligate in fiscal year 2025?

Grants under 93.326 obligated $54,107,744 in federal funds in fiscal year 2025.

Are there open grant opportunities under 93.326?

1 of the latest 47 opportunities under 93.326 is open or forecasted. The latest, Enhancing Understanding of and Preparedness for Public Health Threats Through Research in Kenya, was posted on December 11, 2025.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program